... to the right and the addition of further residues at the N-terminus or beyond residue 34 of the inhibitorysegment is superfluous. However, in the case of PpPr, the serendipitous positioning of ... Thus, there is a need to under-stand the mechanisms of action of the few that areknown, in order to exploit their therapeutic potential[1]. We have described previously one such inhibitor: the ... achieved by location of the full-length extensionat the N-terminal end of the polypeptide. The benefit of these alterations at each extremity of the polypeptidechain, must of necessity arise from...